Geron Corp reports 4Q and annual 2005 financial results and events. [2 tables].

(From Chemical Business NewsBase - Company Reports - CBNB)

Geron Corp reported financial results for 4Q and year ended Dec 2005. Net loss for 4Q 2005 was $8.9 M (net loss of $9.5 M for 4Q 2004). For 2005, the company had a net loss of $33.5 M (net loss of $80.4 M in 2004). In 4Q 2005, the company had revenues of $755,000 ($338,000 for 4Q 2004). For 2005, the company had revenues of $6.2 M ($1.1 M in 2004). Research and development expenses were $9.6 M for 4Q 2005 and $35.080 M for 2005 ($7.985 M in 4Q 2004 and $30.084 M in 2004). Geron is a biopharmaceutical …